This website is provided for informational and educational purposes only
It is important to note that having potential risk factors does not preclude tirzepatide use, but rather indicates the need for patient education, appropriate monitoring during treatment initiation, and readily available emergency management resources
CMS has not provided any projections publicly, but a previous KFF analysis estimated that in 2020 close to 14 million Medicare beneficiaries were overweight or obese
While GLP-1 drugs like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are not FDA-approved for joint pain treatment, emerging evidence suggests they may provide indirect benefits through substantial weight loss
Photomicrographs were taken with an Eclipse TE 2000-U microscope (Nikon)
Activities such as brisk walking, swimming, or cycling can be particularly beneficial